What is Agragene?
Founded in 2017 and currently headquartered in St. Louis, Missouri, Agragene specializes in the development of eco-friendly biological pest control products. The company utilizes proprietary CRISPR technology to engineer solutions that target specific insect pests, such as the spotted wing drosophila, without the environmental degradation associated with conventional pesticides. With a dual focus on domestic commercialization and a robust international licensing strategy, Agragene is effectively bridging the gap between laboratory-scale genetic innovation and large-scale agricultural application. Its market position is defined by its ability to provide scalable, precision-based alternatives for both organic and conventional farming operations worldwide.
How much funding has Agragene raised?
Agragene has raised a total of $7.2M across 2 funding rounds:
Angel/Seed
$1.2M
Series A
$6M
Angel/Seed (2020): $1.2M with participation from Ospraie Management , LLC
Series A (2023): $6M led by Ospraie Ag Science and BioGenerator
Key Investors in Agragene
Ospraie Management, LLC
A specialized investment firm focused on the global agricultural and commodities sectors, providing strategic capital to companies driving innovation in food production.
Ospraie Ag Science
The dedicated agricultural technology arm of Ospraie Management, concentrating on high-growth ventures that improve efficiency and sustainability in the agricultural supply chain.
BioGenerator
Based in St. Louis, Missouri, BioGenerator creates and grows innovative companies through its two complementary approaches, investing through BioGenerator Ventures and comprehensive startup support through BioGenerator Labs.
What's next for Agragene?
With the recent infusion of capital, Agragene is poised to accelerate its commercial product launch within the United States while simultaneously scaling its global licensing operations. The company's strategic roadmap involves deepening its R&D capabilities to expand its portfolio of pest-specific biological agents. As the agricultural sector faces increasing regulatory pressure to reduce chemical usage, Agragene's genome-engineered platform is well-positioned to capture significant market share. Future growth will likely be driven by strategic partnerships with global agribusiness entities, enabling the firm to deploy its technology across diverse geographic markets and crop types, thereby solidifying its role as a leader in the next generation of sustainable crop protection.
See full Agragene company page
